![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Explore this week’s CC Journal Club 90‑sec video • 4‑min audio • paper abstracts |
HIV Infection |
Free Subscription
5 AIDS |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO HIV Infection is free of charge.
Impaired autonomic cardiovascular control in people with HIV on long-term
successful treatment.
AIDS. 2025 Apr 10. doi: 10.1097/QAD.0000000000004208.
PubMed
Abstract available
Modeling the potential impact of viral load monitoring on vertical transmission
of HIV in Kenya.
AIDS. 2025 Apr 10. doi: 10.1097/QAD.0000000000004207.
PubMed
Abstract available
Senescence-related cytokine levels are associated with HIV-1 serostatus and
persistence.
AIDS. 2025 Apr 9. doi: 10.1097/QAD.0000000000004204.
PubMed
Abstract available
Predictors of unsuppressed viral load among men who have sex with men living with
HIV in South Africa.
AIDS. 2025 Apr 9. doi: 10.1097/QAD.0000000000004205.
PubMed
Abstract available
The transmembrane nucleoporin Nup210 weakens HIV-1 infection via modulating late
events of viral nuclear import.
AIDS. 2025 Apr 9. doi: 10.1097/QAD.0000000000004206.
PubMed
Abstract available
Sequence Notes: Characterization of the Near-Full-Length Genome of Two Novel
Unique Recombinant Genome (CRF01_AE/CRF79_0107, CRF01_AE/CRF07_BC) in Hebei,
China.
AIDS Res Hum Retroviruses. 2025 Apr 10. doi: 10.1089/aid.2024.0127.
PubMed
Abstract available
The Association Between the History of Switching Antiretroviral Therapy Regimens
and Lipid Profile in People Living with HIV: A Retrospective Study.
AIDS Res Hum Retroviruses. 2025 Apr 7. doi: 10.1089/aid.2024.0079.
PubMed
Abstract available
Markers of neutrophil activation and some immune and haematological indices in
malaria infection during pregnancy.
BMC Immunol. 2025;26:28.
PubMed
Abstract available
The Need for Lenacapavir Compulsory Licences in Ending the HIV Epidemic.
Clin Infect Dis. 2025 Apr 9:ciaf115. doi: 10.1093.
PubMed
Abstract available
Lenacapavir for Human Immunodeficiency Virus (HIV) Prevention: A Commitment to
Equitable Access and Partnership by Gilead Sciences.
Clin Infect Dis. 2025 Apr 9:ciaf116. doi: 10.1093.
PubMed
Abstract available
Viral suppression, viral failure and safety outcomes in children and adolescents
living with HIV on dolutegravir in Europe and Thailand.
Clin Infect Dis. 2025 Apr 11:ciaf191. doi: 10.1093.
PubMed
Abstract available
mRNA vaccines against HIV: Hopes and challenges.
HIV Med. 2025 Apr 7. doi: 10.1111/hiv.70024.
PubMed
Abstract available
Efficacy of long-acting cabotegravir plus rilpivirine in viraemic people living
with HIV: A systematic review and meta-analysis.
HIV Med. 2025 Apr 9. doi: 10.1111/hiv.70025.
PubMed
Abstract available
Cutaneous Cryptococcosis in a Syphilis Patient Newly Diagnosed With Advanced HIV.
Int J Dermatol. 2025 Apr 9. doi: 10.1111/ijd.17777.
PubMed
The Disparities of PrEP Adherence Among Men Who Have Sex With Men Between the
Global South and the Global North: An Updated Determinantal Global Meta-Analysis.
J Acquir Immune Defic Syndr. 2025;99:1-8.
PubMed
Abstract available
Sexually transmitted infection testing integrated with HIV prevention and
contraceptive services in hair salons in urban South Africa.
J Acquir Immune Defic Syndr. 2025 Apr 7. doi: 10.1097/QAI.0000000000003677.
PubMed
Abstract available
Markers of inflammation and immune dysfunction and non-AIDS cancer risk in adults
with HIV.
J Acquir Immune Defic Syndr. 2025 Apr 7. doi: 10.1097/QAI.0000000000003667.
PubMed
Abstract available
Preferences for PrEP Implementation and Engagement in the HIV Pre-Exposure
Prophylaxis (PrEP) Care Continuum among Patients Receiving Psychiatric Care in an
Ending the HIV Epidemic Priority County.
J Acquir Immune Defic Syndr. 2025 Apr 7. doi: 10.1097/QAI.0000000000003675.
PubMed
Abstract available
HIV Viral Rebound on Dolutegravir, Lopinavir and Efavirenz: National Program Data
Analysis from Ukraine.
J Acquir Immune Defic Syndr. 2025 Apr 7. doi: 10.1097/QAI.0000000000003676.
PubMed
Abstract available
Cost and cost-effectiveness of online recruitment to increase HIV self-testing
among Black and Hispanic/Latino men who have sex with men in the United States,
2020-2021.
J Acquir Immune Defic Syndr. 2025 Apr 7. doi: 10.1097/QAI.0000000000003666.
PubMed
Abstract available
Incremental cost of pre- and post-exposure prophylaxis service provision via an
online pharmacy in Kenya.
J Acquir Immune Defic Syndr. 2025 Apr 8. doi: 10.1097/QAI.0000000000003680.
PubMed
Abstract available
Trends in HIV preexposure prophylaxis use before and after launch of the Ending
the HIV Epidemic in the U.S. initiative, 2016-2023.
J Acquir Immune Defic Syndr. 2025 Apr 8. doi: 10.1097/QAI.0000000000003674.
PubMed
Abstract available
Plasma Inflammatory Biomarkers Link to Worse Cognition Among Africans with HIV.
J Acquir Immune Defic Syndr. 2025 Apr 8. doi: 10.1097/QAI.0000000000003679.
PubMed
Abstract available
Men's Voices on Long-Acting Pre-Exposure Prophylaxis Delivery Modalities:
Acceptability and Preferences Among Cisgender Men and Men Who Have Sex With Men
in South Africa.
J Acquir Immune Defic Syndr. 2025;99:55-63.
PubMed
Abstract available
Retention and viral suppression with differentiated time or space for adolescent
and young adult HIV care: a systematic review and meta-analysis.
J Acquir Immune Defic Syndr. 2025 Apr 8. doi: 10.1097/QAI.0000000000003681.
PubMed
Abstract available
Tuberculous meningitis across the lifespan.
J Infect Dis. 2025 Apr 8:jiaf181. doi: 10.1093.
PubMed
Abstract available
Research strategies of the N-peptide fusion inhibitor: a promising direction for
discovering novel antivirals.
J Virol. 2025 Apr 10:e0228924. doi: 10.1128/jvi.02289.
PubMed
Abstract available
Persistence of CMV-specific anti-HIV CAR T cells after adoptive immunotherapy.
J Virol. 2025 Apr 10:e0193324. doi: 10.1128/jvi.01933.
PubMed
Abstract available
CPSF6 promotes HIV-1 preintegration complex function.
J Virol. 2025 Apr 9:e0049025. doi: 10.1128/jvi.00490.
PubMed
Abstract available
Safety, pharmacokinetics, and biological activity of CD4-mimetic BNM-III-170 in
SHIV-infected rhesus macaques.
J Virol. 2025 Apr 7:e0006225. doi: 10.1128/jvi.00062.
PubMed
Abstract available
Long-acting HIV preventive treatments for remote rural communities.
Lancet. 2025;405:1143.
PubMed
Protecting Africa's children from extreme risk: a runway of sustainability for
PEPFAR programmes.
Lancet. 2025 Apr 8:S0140-6736(25)00401-5. doi: 10.1016/S0140-6736(25)00401.
PubMed
Abstract available
Accelerating domestic investments to end AIDS in Africa.
Lancet. 2025 Apr 8:S0140-6736(25)00685-3. doi: 10.1016/S0140-6736(25)00685.
PubMed
Author Correction: Pay-it-forward incentives for hepatitis virus testing in men
who have sex with men: a cluster randomized trial.
Nat Med. 2025 Apr 9. doi: 10.1038/s41591-025-03690.
PubMed
Clinical and Immunologic Impact of CMV Coinfection Among Children Living With HIV
in Canada.
Pediatr Infect Dis J. 2025 Apr 3. doi: 10.1097/INF.0000000000004811.
PubMed
Abstract available
Commentary: Pediatric HIV Treatment: Nurturing Access Through Health Facility
Availability and Stock-out Monitoring.
Pediatr Infect Dis J. 2025 Apr 3. doi: 10.1097/INF.0000000000004814.
PubMed
Factors associated with the prevalence of viral hepatitis B and C among
prisoners: Results of two consecutive national surveys in Montenegro.
PLoS One. 2025;20:e0321464.
PubMed
Abstract available
Prevalence and factors associated with adverse drug reactions among patients on
highly active antiretroviral therapy at a tertiary hospital in south western
Uganda: A cross-sectional study.
PLoS One. 2025;20:e0321015.
PubMed
Abstract available
Prevalence of HIV and willingness to uptake preventive services among female sex
workers in Kano State, Nigeria.
PLoS One. 2025;20:e0319942.
PubMed
Abstract available
Causal mediation analysis for time-to-event outcomes on the Restricted Mean
Survival Time scale: A pseudo-value approach.
PLoS One. 2025;20:e0319074.
PubMed
Abstract available
Improving HIV outcomes in Miami's Black populations with clinic-based community
health workers protocol: The integrated navigation and support for treatment
adherence, counseling, and research (INSTACARE) randomized controlled trial.
PLoS One. 2025;20:e0316300.
PubMed
Abstract available
The splicing factor kinase, SR protein kinase 1 (SRPK1) is essential for late
events in the human papillomavirus life cycle.
PLoS Pathog. 2025;21:e1012697.
PubMed
Abstract available
A targeted CRISPR screen identifies ETS1 as a regulator of HIV-1 latency.
PLoS Pathog. 2025;21:e1012467.
PubMed
Abstract available
Thank you for your interest in scientific medicine.